Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2163-11-3
146395-14-4
60221-37-6
658858-65-2
92417-25-9
128660-97-9
100-23-2 | Benzenamine, N,N-dimethyl-4-nitro- | AA00002U | MFCD00014712
1000304-40-4 | 3-Azatricyclo[5.1.1.02,5]nonan-4-one, 6,8,8-trimethyl-, (1S,2S,5R,6S,7S)- | AA00008S | MFCD11505102
1000519-40-3 | 3-(4-(Trifluoromethoxy)phenyl)propan-1-ol | AA0000M7 | MFCD09927393
1001108-64-0 | 2-(Carboxymethyl)phenylboronic acid | AA0000W7 | MFCD08704668
1002104-07-5 | 2H-Tetrazole-5-acetic acid, hydrazide | AA00016K | MFCD18071020
10030-67-8 | D-Melezitose dihydrate | AA0001GC | MFCD00149449
1003709-39-4 | 2-Bromo-4-fluoro-5-methylbenzoic acid | AA0001P9 | MFCD09263434
1004643-68-8 | 1-Propyl-1h-pyrazole-5-carboxylic acid | AA0001Z5 | MFCD04970195
1006-08-2 | 7-Methyl-7h-purin-6-ol | AA0002CR | MFCD00047227
4522-35-4 | 3-Iodopyrazole | AA0002OI | MFCD12022324